Literature DB >> 23611191

Confidence interval estimation for sensitivity at a fixed level of specificity for combined biomarkers.

Lili Tian1.   

Abstract

In diagnostic studies, we often need to combine several biomarkers to increase the diagnostic accuracy. For continuous-scaled biomarkers or diagnostic tests, it is often of interest to estimate the confidence interval for sensitivity at a fixed level of specificity. Despite the fact that there exist many literature reports on confidence interval estimation of sensitivity at a fixed level of specificity for a single marker, the inference procedures for sensitivity at a fixed level of specificity for combined markers have rarely been addressed. This article fills this gap by investigating a generalized variable procedure for this purpose. The performance of the proposed generalized approach is numerically studied. For the optimal linear combination proposed by Su and Liu ( 1993 ), simulation study demonstrates that the proposed approach generally can provide confidence intervals with excellent coverage probabilities. The robustness of the proposed approach is investigated for categorical data. In the end, the proposed approach is applied to a real-life data set.

Mesh:

Substances:

Year:  2013        PMID: 23611191     DOI: 10.1080/10543406.2011.616967

Source DB:  PubMed          Journal:  J Biopharm Stat        ISSN: 1054-3406            Impact factor:   1.051


  1 in total

1.  Empirical likelihood confidence interval for sensitivity to the early disease stage.

Authors:  Husneara Rahman; Yichuan Zhao
Journal:  Pharm Stat       Date:  2021-12-27       Impact factor: 1.234

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.